Tg Therapeutics (TGTX) Current Leases (2019 - 2026)
Tg Therapeutics (TGTX) posted quarterly Current Leases of $1.8 million for Q1 2026, up 63.26% year-over-year from $1.1 million in Q1 2025, and up 74.52% quarter-over-quarter from $1.0 million in Q4 2025.
Tg Therapeutics (TGTX) Current Leases (2019 - 2026) Analysis & Trends
Tg Therapeutics' Current Leases history runs 8 years deep, the most recent figure standing at $1.8 million for Q1 2026.
- In Q1 2026, Current Leases rose 63.26% year-over-year to $1.8 million; the TTM figure through Mar 2026 stood at $1.8 million (up 63.26% YoY), while the FY2025 annual figure was $1.0 million, down 9.77% from the prior year.
- Current Leases for Q1 2026 stood at $1.8 million, up from $1.0 million in the prior quarter.
- The five-year high for Current Leases was $1.8 million in Q1 2026, with the low at $1.0 million in Q4 2025.
- The 5-year median for Current Leases is $1.4 million (2023), against an average of $1.4 million.
- The sharpest annual moves came in 2024 and 2026: Current Leases declined 19.99% in 2024, then jumped 63.26% in 2026.
- Tg Therapeutics' Current Leases stood at $1.6 million in 2022, then dropped by 8.54% to $1.4 million in 2023, then fell by 19.99% to $1.2 million in 2024, then slipped by 9.77% to $1.0 million in 2025, then surged by 74.52% to $1.8 million in 2026.
- Business Quant data shows TGTX's Current Leases at $1.8 million in Q1 2026, $1.0 million in Q4 2025, and $1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 11.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 16.75 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 21.95 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 2.24 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 45.93 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.27 Mn |
| 10 | Tg Therapeutics | 7.46 Bn | 6.78 Bn | 199.14 Mn | 1.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.91 Mn |
| Mar 31, 2026 | 1.82 Mn |
| Dec 31, 2025 | 1.04 Mn |
| Sep 30, 2025 | 1.07 Mn |
| Jun 30, 2025 | 1.09 Mn |
| Mar 31, 2025 | 1.12 Mn |
| Dec 31, 2024 | 1.16 Mn |
| Sep 30, 2024 | 1.23 Mn |
| Jun 30, 2024 | 1.31 Mn |
| Mar 31, 2024 | 1.38 Mn |
| Dec 31, 2023 | 1.45 Mn |
| Sep 30, 2023 | 1.48 Mn |
| Jun 30, 2023 | 1.51 Mn |
| Mar 31, 2023 | 1.55 Mn |
| Dec 31, 2022 | 1.58 Mn |
| Sep 30, 2022 | 1.62 Mn |
| Jun 30, 2022 | 1.48 Mn |
| Mar 31, 2022 | 1.49 Mn |
| Dec 31, 2021 | 1.44 Mn |
| Sep 30, 2021 | 1.47 Mn |